Sanofi ADR [NASDAQ: SNY] stock went on a downward path that fall over -1.59% on Thursday, amounting to a one-week price decrease of less than -5.12%.
Over the last 12 months, SNY stock dropped by -0.54%. The one-year Sanofi ADR stock forecast points to a potential upside of 15.68. The average equity rating for SNY stock is currently 1.90, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $130.50 billion, with 2.51 billion shares outstanding and 2.51 billion shares in the current float. Compared to the average trading volume of 1.77M shares, SNY stock reached a trading volume of 3303602 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Sanofi ADR [SNY]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SNY shares is $61.73 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SNY stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Argus have made an estimate for Sanofi ADR shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 26, 2024. While these analysts kept the previous recommendation, Morgan Stanley raised their target price to Equal-Weight. The new note on the price target was released on January 23, 2024, representing the official price target for Sanofi ADR stock.
The Average True Range (ATR) for Sanofi ADR is set at 0.98, with the Price to Sales ratio for SNY stock in the period of the last 12 months amounting to 2.74. The Price to Book ratio for the last quarter was 1.67, with the Price to Cash per share for the same quarter was set at 2.90. Price to Free Cash Flow for SNY in the course of the last twelve months was 22.15 with Quick ratio for the last quarter at 0.65.
SNY Stock Performance Analysis:
Sanofi ADR [SNY] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.12. With this latest performance, SNY shares dropped by -8.12% in over the last four-week period, additionally plugging by 5.45% over the last 6 months – not to mention a drop of -0.54% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SNY stock in for the last two-week period is set at 25.51, with the RSI for the last a single of trading hit 17.38, and the three-weeks RSI is set at 32.89 for Sanofi ADR [SNY]. The present Moving Average for the last 50 days of trading for this stock 56.03, while it was recorded at 53.36 for the last single week of trading, and 50.76 for the last 200 days.
Insight into Sanofi ADR Fundamentals:
Sanofi ADR’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.65 and a Current Ratio set at 1.00.
SNY Stock EPS
With the latest financial reports released by the company, Sanofi ADR posted 2.77/share EPS, while the average EPS was predicted by analysts to be reported at 1.37/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 1.4. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SNY. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Sanofi ADR go to 7.49%.
Sanofi ADR [SNY] Institutonal Ownership Details
The top three institutional holders of SNY stocks are: DODGE & COX with ownership of 77.11 million shares, which is approximately 3.0873%. FMR LLC, holding 15.21 million shares of the stock with an approximate value of $$738.2 million in SNY stocks shares; and FMR LLC, currently with $$714.89 million in SNY stock with ownership which is approximately 0.5899%.
